Zagreb, January, 2017
Dear Madam / Sir,
Please be informed that 7th Adriatic and 5th Croatian Congress of Pharmacoeconomics and
Outcomes Research will take place in Poreč, Croatia, April 20-23, 2017 and will be organized
by the Institute for Research, Pharmacology and Health Economics (IRPHE) in collaboration with
the Section for Pharmacoeconomics and Outcomes Research of the Croatian Society of Clinical
Pharmacology and Therapeutics, Croatian Physician Association, under the auspices of the
European Society for Clinical Pharmacology and Therapeutics (EACPT).
The main objective of this year congress is to intensify and enhance professional and scientific
discussions between various stakeholders about…
‘How to Manage Access to Medical Innovation in Central and Eastern Europe’
… with the focus to and most case studies presented in the field of oncology as well as to the
transparency and efficiency of national policy development and implementation.
The main topics of this year congress will be:
∗
The importance and impact of the availability and quality of the national
epidemiology data and patient registries on the quality of pharmacoeconomic studies
and rational decision making process in the national healthcare systems, with the focus on
case studies in oncology and similar therapeutic areas with increasing treatment costs
∗
The impact of continuous medical education, national and/or international clinical
guidelines and the efficiency of their implementation and monitoring on the healthcare
outcomes and the sustainability of healthcare financing, with the focus on case studies in
oncology and similar therapeutic areas with increasing treatment costs
∗
The importance of national policy development, availability of tailored health
technology assessment and outcome research processes to study the value innovation
and their impact on healthcare outcomes in developing countries;
∗
The impact of pharmacoeconomic studies on the transparency and competitiveness
of payback / clawback models for expensive medicines, connecting the dots between
the value and the price
∗
The role and importance of generic medicines and biosimilars to the sustainability of
healthcare financing and the impact to national economy, with the focus to impact
analysis of the recent off patent oncology medication, with focus to case studies of recent
and near future off patent oncology medicines.
∗
The impact of clinical trial conduct on the healthcare outcomes, national health
insurance funds and national economy in 'clinical trial friendly and competitive'
countries
Final congress agenda will also comprise other important topics as proposed and submitted by
independent and respected Authors and accepted by the Congress Scientific Committee.
Based on previous experience and recognized regional importance of this congress, around 200
attendees and active contributors are expected, from more than 10 countries of Central, South and
East Europe, mostly scientists and researchers in the field of health economics and outcomes
research.
If you find this program scientifically interesting we would highly appreciate and value your
sponsorship and could offer you the following Sponsorship Options:
PLATINUM SPONSOR
- would be entitled to receive:
1. Publication of Company’s name and logo, in the group of Platinum Sponsors, on all
Congress promotional materials published after the receipt of sponsorship payment;
2. Large Company logo, published next to the Congress name and main topic, on all official
Congress posters;
3. Company name published by means of LCD projection, in the group of Platinum Sponsors,
during opening and closing ceremonies, before and after all presentation sessions, and
during coffee breaks.
4. One Corporate promotional page in the final Congress Programme
5. One Corporate promotional page in the Congress Abstract book.
6. Suggestion of three topics of interest to be covered during the congress, one of which will
be chosen by Congress Scientific Committee for the inclusion in Congress Final
Programme.
7. Two free registrations for the congress attendance
The right to be presented as a Platinum Sponsor can be ensured by timely payment of 7.500,00
EUR + VAT.
GOLD SPONSOR
- is entitled to receive:
1. Publication of Company’s name and logo, in the group of Gold Sponsors, on all Congress
promotional materials published after the receipt of sponsorship payment;
2. Medium size Company logo, published next to the Congress name and main topic, on all
official Congress posters;
3. Company name published by means of LCD projection, in the group of Gold
Sponsors, during opening and closing ceremonies, before and after all presentation
sessions, and during coffee breaks.
4. Half Corporate promotional page in the final Congress Programme
5. Half Corporate promotional page in the Congress Abstract book.
6. One free registrations for the congress attendance
The right to be presented as a Gold Sponsor can be ensured by timely payment of 5.000,00 EUR +
VAT.
SILVER SPONSOR
- is entitled to receive:
1. Publication of Company’s name and logo, in the group of Silver Sponsors, on all Congress
promotional materials published after the receipt of sponsorship payment;
2. Small size Company logo, published next to the Congress name and main topic, on all
official Congress posters;
3. Company name published by means of LCD projection, in the group of Silver Sponsors,
during opening and closing ceremonies, before and after all presentation sessions, and
during coffee breaks.
4. One quarter of Corporate promotional page in the final Congress Programme
5. One quarter of Corporate promotional page in the Congress Abstract book.
The right to be presented as a Silver Sponsor can be ensured by timely payment of 2.500,00 EUR +
VAT.
BRONZE SPONSOR
- is entitled to receive:
1. Publication of Company’s name and logo, in the group of Bronze Sponsors, on all Congress
promotional materials published after the receipt of sponsorship payment;
2. Small size Company logo, published next to the Congress name and main topic, on all
official Congress posters;
3. Company name published by means of LCD projection, in the group of Bronze Sponsors,
during opening and closing ceremonies.
4. Small size Company logo, published in the final Congress Programme
5. Small size Company logo, published in the Congress Abstract book.
The right to be presented as a Bronze Sponsor can be ensured by timely payment of 1.500,00 EUR
+ VAT.
For any further information please contact Congress Technical Organizer:
Ms. Tatjana Koprtla, O-Tours d.o.o, Gajeva 6/1, Zagreb (mobile: +385.98.9805.716; office:
+385.1.4831.444, fax: +385.1.4813.010).
Sponsorship payments are to be transferred to the bank account of the Congress Technical
Organizer before March 15, 2016: Swift kod: RZBHHR2X, IBAN: HR9624840081500154837;
Poziv na broj: 02-041-000; Payment description: ‘kongres farmakoekonomike’.
We are looking forward to hearing from you and welcoming you at the 7th Adriatic and 5th
Croatian Congress of Pharmacoeconomics and Outcomes Research.
Respectfully Yours,
Prof. Dinko Vitezić, MD, PhD
Congress President, and
President, Croatian Society for Clinical Pharmacology and Therapeutics